title: Molecular cloning and characterization of the human A3 adenosine receptor.
abstract: The human A3 adenosine receptor was cloned from a striatal cDNA library using a probe derived from the homologous rat sequence. The cDNA encodes a protein of 318 amino acids and exhibits 72% and 85% overall identity with the rat and sheep A3 adenosine receptor sequences, respectively. Specific and saturable binding of the adenosine receptor agonist N6-(4-amino-3-[125I]iodobenzyl)adenosine [125I]ABA was measured on the human A3 receptor stably expressed in Chinese hamster ovary cells with a Kd = 10 nM. The potency order for adenosine receptor agonists was N-ethylcarboxamidoadenosine (NECA) > or = (R)-N6-phenyl-2-propyladenosine [(R)-PIA] > N6-cyclopentyladenosine (CPA) > (S)-N6-phenyl-2-propyladenosine [(S)-PIA]. The human receptor was blocked by xanthine antagonists, most potently by 3-(3-iodo-4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propylxanthine (I-ABOPX) with a potency order of I-ABOPX > 1,3-dipropyl-8-(4-acrylate)phenylxanthine > or = xanthine amino congener >> 1,3-dipropyl-8-cyclopentylxanthine. Adenosine, NECA, (R)- and (S)-PIA, and CPA inhibited forskolin-stimulated cAMP accumulation by 30-40% in stably transfected cells; I-ABA is a partial agonist. When measured in the presence of antagonists, the dose-response curves of NECA-induced inhibition of forskolin-stimulated cAMP accumulation were right-shifted. Antagonist potencies determined by Schild analyses correlated well with those established by competition for radioligand binding. The A3 adenosine receptor transcript is widespread and, in contrast to the A1, A2a, and A2b transcripts, the most abundant expression is found in the lung and liver. The tissue distribution of A3 mRNA is more similar to the widespread profile found in sheep than to the restricted profile found in the rat. This raises the possibility that numerous physiological effects of adenosine may be mediated by A3 adenosine receptors.
authors.affiliation: Department of Pharmacology, Merck Research Laboratories, West Point, PA 19486.
authors.forename: C A
authors.initials: CA
authors.lastname: Salvatore
authors.forename: M A
authors.initials: MA
authors.lastname: Jacobson
authors.forename: H E
authors.initials: HE
authors.lastname: Taylor
authors.forename: J
authors.initials: J
authors.lastname: Linden
authors.forename: R G
authors.initials: RG
authors.lastname: Johnson
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D001667:Binding, Competitive; D016466:CHO Cells; D003001:Cloning, Molecular; D016384:Consensus Sequence; D003342:Corpus Striatum / Q000378:metabolism*; D006224:Cricetinae; D017931:DNA Primers; D015870:Gene Expression; D006801:Humans; D007462:Iodobenzenes / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D051381:Rats; D018047:Receptors, Purinergic P1 / Q000096:biosynthesis* / Q000378:metabolism*; D017386:Sequence Homology, Amino Acid; D012756:Sheep; D014162:Transfection
chemical_list: D017931:DNA Primers; D007462:Iodobenzenes; D018047:Receptors, Purinergic P1; C044323:3-iodo-N(6)-4-aminobenzyladenosine; D000241:Adenosine